✦ LIBER ✦

A25. Clinical experience with the nitric oxide synthase inhibitor N-nitro-l-Arginine (LNNA) in malignant disease

✍ Scribed by P.J. Hoskin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-nitro-l-arginine, a nitric oxide synth

✍ Haseeb Ahmad Khan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 627 KB

Effects of N-nitro-L-arginine, a nitric

✍ C. Pedraza; J.F. Navarro; L.J. Santín; J.L. Arias 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A Nitric Oxide Synthase Inhibitor NG-Nit

✍ D.A. Czech 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Nω-Nitro-L-Arginine, a Nitric Oxide Synt

✍ Daniel Santamaría; Velia Espinoza-González; Camilo Ríos; Abel Santamaría 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 548 KB

NG-nitro-L-arginine methylester, a nitri

✍ Motoaki Saito; Ikuo Miyagawa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Chronic administration of a nitric oxide

✍ M. Bansinath; B. Arbabha; H. Turndorf; U. C. Garg 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 410 KB